Literature DB >> 11117569

Effect of transjugular intrahepatic portosystemic shunt on thrombocytopenia associated with cirrhosis.

Z Karasu1, A Gurakar, B Kerwin, S Hulagu, A Jazzar, R McFadden, B Nour, A Sebastian, F Cassidy, K Stokes, D H Van Thiel, H Wright.   

Abstract

Thrombocytopenia is a frequent complication of cirrhosis. Its pathogenesis is not well known, but it has been suggested that splenic congestion induced by portal hypertension may be a major contributory factor. However, the available data regarding the effect of portal decompression either by surgical shunts or transjugular intrahepatic portosystemic shunt (TIPS) on peripheral platelet count in cirrhotics is conflicting. We studied the effects of TIPS on platelet count and mean platelet volume, following a successful TIPS placement. The platelet count had a tendency to decrease but was not statistically significant (120,100 +/- 72,100/mm3 before TIPS vs 99,800 +/- 51,400/mm3 after TIPS). The mean platelet volume remained essentially unchanged (9.8 +/- 1.5 fL before TIPS and 9.9 +/- 1.5 fL after TIPS). These results confirm that TIPS has an unpredictable effect on platelet count in cirrhotic patients with thrombocytopenia. The lack of a consistent increase in the peripheral mean platelet volume following TIPS placement suggests that TIPS is unable to significantly enhance the release of platelets sequestered in the splenic compartment in portal hypertension.

Entities:  

Mesh:

Year:  2000        PMID: 11117569     DOI: 10.1023/a:1005694617983

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  53 in total

1.  Portasystemic venous shunts (first of two parts).

Authors:  R A Malt
Journal:  N Engl J Med       Date:  1976-07-01       Impact factor: 91.245

2.  Effect of portasystemic shunt on hypersplenism: clinical study in 129 patients with cirrhosis.

Authors:  M Puttini; A Marni; F Montes; L Belli
Journal:  Am Surg       Date:  1979-07       Impact factor: 0.688

3.  Platelet changes following clinical and experimental hepatic homotransplantation.

Authors:  D E Hutchison; E Genton; K A Porter; P M Daloze; C Huguet; L Brettschneider; C G Groth; T E Starzl
Journal:  Arch Surg       Date:  1968-07

4.  Evidence that the spleen retains the youngest and hemostatically most effective platelets.

Authors:  N R Shulman; S P Watkins; S B Itscoitz; A B Students
Journal:  Trans Assoc Am Physicians       Date:  1968

5.  Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation.

Authors:  T G Martin; K A Somberg; Y G Meng; R L Cohen; C A Heid; F J de Sauvage; M A Shuman
Journal:  Ann Intern Med       Date:  1997-08-15       Impact factor: 25.391

6.  The influence fo traumatic splenectomy on the volume of human platelets.

Authors:  N Laufer; H Freund; I Charuzi; N B Grover
Journal:  Surg Gynecol Obstet       Date:  1978-06

7.  Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function.

Authors:  C B Thompson; K A Eaton; S M Princiotta; C A Rushin; C R Valeri
Journal:  Br J Haematol       Date:  1982-03       Impact factor: 6.998

8.  Effect of portacaval anastomosis on hypersplenism.

Authors:  M G Mutchnick; E Lerner; H O Conn
Journal:  Dig Dis Sci       Date:  1980-12       Impact factor: 3.199

9.  Direct evidence for an increase in thrombopoiesis after liver transplantation.

Authors:  G Stiegler; P Stohlawetz; M Peck-Radosavljevic; B Jilma; J Pidlich; M Wichlas; P Höcker; S Panzer
Journal:  Eur J Clin Invest       Date:  1998-09       Impact factor: 4.686

10.  Course of thrombocytopenia of chronic liver disease after transjugular intrahepatic portosystemic shunts (TIPS). A retrospective analysis.

Authors:  S P Lawrence; D C Lezotte; J D Durham; D A Kumpe; G T Everson; B M Bilir
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

View more
  8 in total

Review 1.  New insights into the coagulopathy of liver disease and liver transplantation.

Authors:  M Senzolo; P Burra; E Cholongitas; A-K Burroughs
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

2.  The Effect of Transjugular Intrahepatic Portosystemic Shunt on Platelet Counts in Patients With Liver Cirrhosis.

Authors:  Omar I Massoud; Nizar N Zein
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-05

Review 3.  Abnormal hematological indices in cirrhosis.

Authors:  A A Qamar; N D Grace
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522

4.  Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis.

Authors:  Elise J Barney; Ester C Little; Richard D Gerkin; Alberto X Ramos; Jeffrey Kahn; Mark Wong; Geetha Kolli; Richard Manch
Journal:  Dig Dis Sci       Date:  2012-05-16       Impact factor: 3.199

5.  Efficacy and safety of laparoscopic splenectomy for hypersplenism secondary to portal hypertension after transjugular intrahepatic portosystemic shunt.

Authors:  Yingying Li; Zuojin Liu; Chang'an Liu
Journal:  BMC Gastroenterol       Date:  2021-02-11       Impact factor: 3.067

6.  Prediction of Patient Survival with Psoas Muscle Density Following Transjugular Intrahepatic Portosystemic Shunts: A Retrospective Cohort Study.

Authors:  Biyu Zhang; Weimin Cai; Feng Gao; Xinran Lin; Ting Qian; Kaier Gu; Bingxin Song; Tanzhou Chen
Journal:  Med Sci Monit       Date:  2022-01-15

Review 7.  Thrombocytopenia in Chronic Liver Disease: Challenges and Treatment Strategies.

Authors:  Shreya Desai; Anita Subramanian
Journal:  Cureus       Date:  2021-07-12

8.  Utility of Doppler ultrasonography for predicting improvement of platelet count after transjugular intrahepatic portosystemic shunt.

Authors:  Kianoush Ansari-Gilani; Babak Seddigh Tonekaboni; Dean A Nakamoto; Jamak Modaresi Esfeh
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-10-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.